{"id":6623,"date":"2026-08-11T12:44:03","date_gmt":"2026-08-11T12:44:03","guid":{"rendered":"https:\/\/tsubaki-jp.com\/?p=6623"},"modified":"2026-08-12T05:32:30","modified_gmt":"2026-08-12T05:32:30","slug":"fda-approval-japan-availability-unapproved-drugs-council-ja","status":"publish","type":"post","link":"https:\/\/tsubaki-jp.com\/ja\/fda-approval-japan-availability-unapproved-drugs-council-ja\/","title":{"rendered":"\u300cFDA\u627f\u8a8d\u300d\u306f\u65e5\u672c\u3067\u4f55\u3092\u610f\u5473\u3057\u3001\u4f55\u3092\u610f\u5473\u3057\u306a\u3044\u306e\u304b"},"content":{"rendered":"<p>\u56fd\u5185\u306e\u696d\u754c\u30e1\u30c7\u30a3\u30a2\u306f\u3001\u524d\u6708\u306b\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08FDA\uff09\u304c\u627f\u8a8d\u3057\u305f\u533b\u85ac\u54c1\u306e\u6708\u6b21\u307e\u3068\u3081\u3092\u63b2\u8f09\u3057\u3066\u3044\u307e\u3059\u30022026\u5e747\u6708\u5206\u306f8\u67087\u65e5\u4ed8\u3067\u3059\u3002\u672c\u8a18\u4e8b\u306f\u500b\u3005\u306e\u54c1\u76ee\u3092\u8ffd\u3046\u306e\u3067\u306f\u306a\u304f\u3001\u3053\u306e\u7a2e\u306e\u307e\u3068\u3081\u304c\u51fa\u308b\u305f\u3073\u306b\u5b9f\u969b\u306b\u5bc4\u305b\u3089\u308c\u308b\u554f\u3044\u306b\u7b54\u3048\u307e\u3059\u3002\u7c73\u56fd\u3067\u627f\u8a8d\u3055\u308c\u305f\u2014\u2014\u305d\u308c\u304c\u65e5\u672c\u306b\u5c4a\u304f\u306e\u306f\u3044\u3064\u3067\u3001\u3069\u306e\u7d4c\u8def\u3092\u901a\u308b\u306e\u304b\u3002<\/p>\n<p><strong>\u4f53\u88c1\u306b\u3064\u3044\u3066\u5148\u306b\u4e00\u70b9\u3002<\/strong>\u4ee5\u4e0b\u3067\u306f\u500b\u3005\u306e\u533b\u85ac\u54c1\u306e\u52b9\u80fd\u30fb\u52b9\u679c\u3001\u7528\u6cd5\u7528\u91cf\u3001\u6709\u52b9\u6027\u30c7\u30fc\u30bf\u306f\u4e00\u5207\u6271\u3044\u307e\u305b\u3093\u3002\u7c73\u56fd\u306e\u627f\u8a8d\u30ea\u30b9\u30c8\u306b\u8f09\u308b\u54c1\u76ee\u306e\u591a\u304f\u306f\u56fd\u5185\u672a\u627f\u8a8d\u3067\u3042\u308a\u3001\u533b\u85ac\u54c1\u533b\u7642\u6a5f\u5668\u7b49\u6cd5\uff08\u85ac\u6a5f\u6cd5\uff09\u306f\u672a\u627f\u8a8d\u533b\u85ac\u54c1\u306b\u3064\u3044\u3066\u516c\u8868\u3067\u304d\u308b\u5185\u5bb9\u3092\u5236\u9650\u3057\u3066\u3044\u307e\u3059\u3002\u672c\u8a18\u4e8b\u306f\u5236\u5ea6\u9762\u306e\u307f\u3092\u6271\u3044\u307e\u3059\u3002<\/p>\n<h2>2026\u5e747\u6708\u306e\u30ea\u30b9\u30c8\u306b\u5b9f\u969b\u306b\u8f09\u3063\u3066\u3044\u308b\u3082\u306e<\/h2>\n<p><strong>FDA\u81ea\u8eab\u306e\u300cNovel Drug Approvals for 2026\u300d\u3067\u306f\u30012026\u5e747\u6708\u4ed8\u306e\u65b0\u85ac\u627f\u8a8d\u306f6\u4ef6\u3067\u3059\uff087\u65e5\u300114\u65e5\u300115\u65e5\u300122\u65e5\u3001\u304a\u3088\u307324\u65e5\u306e2\u4ef6\uff09\u3002<\/strong>\u540c\u30da\u30fc\u30b8\u306f2026\u5e74\u306e\u5e74\u521d\u6765\u306730\u4ef6\u3092\u8a18\u8f09\u3057\u3066\u304a\u308a\u3001\u30da\u30fc\u30b8\u306e\u5185\u5bb9\u57fa\u6e96\u65e5\u306f2026\u5e748\u67085\u65e5\u3067\u3059\u3002<\/p>\n<p>\u51fa\u5178\u3092\u6bd4\u8f03\u3059\u308b\u3068\u304d\u306b\u52b9\u3044\u3066\u304f\u308b\u6ce8\u610f\u70b9\u304c\u3042\u308a\u307e\u3059\u3002FDA\u306e\u3053\u306e\u30ea\u30b9\u30c8\u306fCDER\u304c\u5be9\u67fb\u3057\u305f\u65b0\u6709\u52b9\u6210\u5206\u30fb\u65b0\u898f\u6cbb\u7642\u7528\u751f\u7269\u88fd\u5264\u3092\u6570\u3048\u308b\u3082\u306e\u3067\u3001\u65e2\u627f\u8a8d\u85ac\u306e\u9069\u5fdc\u62e1\u5927\u306f\u542b\u307e\u305a\u3001\u30d0\u30a4\u30aa\u30b7\u30df\u30e9\u30fc\u3082\u542b\u307f\u307e\u305b\u3093\u3002\u696d\u754c\u30e1\u30c7\u30a3\u30a2\u306e\u6708\u6b21\u307e\u3068\u3081\u306f\u901a\u5e38\u3053\u306e\u4e09\u3064\u3092\u307e\u3068\u3081\u3066\u6271\u3046\u305f\u3081\u3001\u540c\u3058\u6708\u3067\u3082\u4ef6\u6570\u306f\u6b63\u5f53\u306b\u5927\u304d\u304f\u306a\u308a\u307e\u3059\u3002\u3069\u3061\u3089\u306e\u6570\u5b57\u3082\u8aa4\u308a\u3067\u306f\u306a\u304f\u3001\u7b54\u3048\u3066\u3044\u308b\u554f\u3044\u304c\u9055\u3044\u307e\u3059\u3002<\/p>\n\n\n<figure class=\"wp-block-image size-full tsubaki-illustration--fda-monthly-count\" data-tsubaki-illustration=\"fda-monthly-count\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/fda-july-six-novel-drug-count-1.webp\" alt=\"Monthly approval register with six marked entries and separate categories outside the FDA novel drug count.\" class=\"wp-image-6654\" width=\"1672\" height=\"941\" srcset=\"https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/fda-july-six-novel-drug-count-1.webp 1672w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/fda-july-six-novel-drug-count-1-300x169.webp 300w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/fda-july-six-novel-drug-count-1-1024x576.webp 1024w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/fda-july-six-novel-drug-count-1-768x432.webp 768w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/fda-july-six-novel-drug-count-1-1536x864.webp 1536w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/fda-july-six-novel-drug-count-1-600x338.webp 600w\" sizes=\"auto, (max-width: 1672px) 100vw, 1672px\" \/><\/figure>\n\n<h2>\u300cFDA\u627f\u8a8d\u300d\u3068\u300c\u65e5\u672c\u3067\u5165\u624b\u53ef\u80fd\u300d\u304c\u5225\u7269\u3067\u3042\u308b\u7406\u7531<\/h2>\n<p>\u7c73\u56fd\u306e\u627f\u8a8d\u306f\u65e5\u672c\u306b\u304a\u3044\u3066\u4f55\u3089\u52b9\u529b\u3092\u6301\u3061\u307e\u305b\u3093\u3002\u65e5\u672c\u3067\u533b\u85ac\u54c1\u3092\u8ca9\u58f2\u3059\u308b\u306b\u306f\u3001\u85ac\u6a5f\u6cd5\u306b\u57fa\u3065\u304f\u65e5\u672c\u306e\u627f\u8a8d\u3092\u5225\u9014\u53d6\u5f97\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u3001\u305d\u306e\u54c1\u76ee\u81ea\u8eab\u306e\u7533\u8acb\u8cc7\u6599\u306b\u3064\u3044\u3066\u65e5\u672c\u5074\u306e\u5be9\u67fb\u304c\u884c\u308f\u308c\u307e\u3059\u3002\u4e8c\u3064\u306e\u5236\u5ea6\u306f\u4e26\u8d70\u3057\u3066\u304a\u308a\u3001\u7c73\u56fd\u3067\u627f\u8a8d\u3055\u308c\u3066\u4f55\u5e74\u3082\u7d4c\u3063\u3066\u304b\u3089\u65e5\u672c\u3067\u306e\u7533\u8acb\u304c\u59cb\u307e\u308b\u3053\u3068\u3082\u3001\u7533\u8acb\u81ea\u4f53\u304c\u884c\u308f\u308c\u306a\u3044\u3053\u3068\u3082\u3042\u308a\u307e\u3059\u3002<\/p>\n<p>\u3053\u306e\u5dee\u304c\u3001\u7c73\u56fd\u306e\u627f\u8a8d\u30ea\u30b9\u30c8\u304c\u65e5\u672c\u306e\u8aad\u8005\u306b\u3068\u3063\u3066\u53c2\u8003\u306b\u306f\u306a\u308b\u304c\u76f4\u63a5\u306f\u52d5\u304b\u305b\u306a\u3044\u7406\u7531\u3067\u3059\u3002\u6709\u7528\u306a\u554f\u3044\u306f\u300c\u627f\u8a8d\u3055\u308c\u305f\u304b\u300d\u3067\u306f\u306a\u304f\u300c\u65e5\u672c\u306e\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u4e0a\u3067\u3069\u3053\u306b\u3044\u308b\u304b\u300d\u3067\u3059\u3002<\/p>\n\n\n<figure class=\"wp-block-image size-full tsubaki-illustration--independent-approval-systems\" data-tsubaki-illustration=\"independent-approval-systems\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/us-japan-independent-approval-systems-1.webp\" alt=\"Parallel United States and Japan regulatory tracks showing that approval in one system does not transfer automatically.\" class=\"wp-image-6655\" width=\"1672\" height=\"941\" srcset=\"https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/us-japan-independent-approval-systems-1.webp 1672w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/us-japan-independent-approval-systems-1-300x169.webp 300w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/us-japan-independent-approval-systems-1-1024x576.webp 1024w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/us-japan-independent-approval-systems-1-768x432.webp 768w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/us-japan-independent-approval-systems-1-1536x864.webp 1536w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/us-japan-independent-approval-systems-1-600x338.webp 600w\" sizes=\"auto, (max-width: 1672px) 100vw, 1672px\" \/><\/figure>\n\n<h2>\u6d77\u5916\u3067\u627f\u8a8d\u6e08\u307f\u306e\u533b\u85ac\u54c1\u3092\u65e5\u672c\u306b\u6301\u3063\u3066\u304f\u308b\u516c\u5f0f\u7d4c\u8def<\/h2>\n<p><strong>\u3053\u306e\u72b6\u6cc1\u306e\u305f\u3081\u306b\u3001\u65e5\u672c\u306b\u306f\u5e38\u8a2d\u306e\u4ed5\u7d44\u307f\u304c\u3042\u308a\u307e\u3059\u3002\u539a\u751f\u52b4\u50cd\u7701\u304c\u958b\u50ac\u3059\u308b\u300c\u533b\u7642\u4e0a\u306e\u5fc5\u8981\u6027\u306e\u9ad8\u3044\u672a\u627f\u8a8d\u85ac\u30fb\u9069\u5fdc\u5916\u85ac\u691c\u8a0e\u4f1a\u8b70\u300d\u3067\u3059\u3002<\/strong>\u5b66\u4f1a\u304c\u8981\u671b\u3092\u63d0\u51fa\u3057\u3001\u4f1a\u8b70\u304c\u533b\u7642\u4e0a\u306e\u5fc5\u8981\u6027\u3092\u8a55\u4fa1\u3057\u307e\u3059\u3002\u5fc5\u8981\u6027\u304c\u8a8d\u3081\u3089\u308c\u305f\u5834\u5408\u3001\u539a\u751f\u52b4\u50cd\u7701\u306f\u4f01\u696d\u306b\u958b\u767a\u8981\u8acb\u3092\u884c\u3046\u304b\u3001\u958b\u767a\u4f01\u696d\u306e\u516c\u52df\u3092\u884c\u3044\u307e\u3059\u3002<\/p>\n\n\n<figure class=\"wp-block-image size-full tsubaki-illustration--official-development-pathway\" data-tsubaki-illustration=\"official-development-pathway\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/japan-unapproved-drug-official-pathway-1.webp\" alt=\"Four-stage illustration of a professional society request, expert review, development request and company development.\" class=\"wp-image-6656\" width=\"1672\" height=\"941\" srcset=\"https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/japan-unapproved-drug-official-pathway-1.webp 1672w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/japan-unapproved-drug-official-pathway-1-300x169.webp 300w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/japan-unapproved-drug-official-pathway-1-1024x576.webp 1024w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/japan-unapproved-drug-official-pathway-1-768x432.webp 768w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/japan-unapproved-drug-official-pathway-1-1536x864.webp 1536w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/japan-unapproved-drug-official-pathway-1-600x338.webp 600w\" sizes=\"auto, (max-width: 1672px) 100vw, 1672px\" \/><\/figure>\n\n<p>\u539a\u751f\u52b4\u50cd\u7701\u304c\u516c\u8868\u3057\u3066\u3044\u308b\u5bfe\u8c61\u7bc4\u56f2\u306f\u6b21\u306e\u4e09\u3064\u3067\u3059\u3002<\/p>\n<ul>\n<li>\u7c73\u56fd\u3001\u82f1\u56fd\u3001\u72ec\u56fd\u3001\u4ecf\u56fd\u3001\u52a0\u56fd\u3001\u8c6a\u5dde\u306e\u3044\u305a\u308c\u304b\u3067\u627f\u8a8d\u3055\u308c\u3066\u3044\u308b\u304c\u3001\u56fd\u5185\u672a\u627f\u8a8d\u306e\u533b\u85ac\u54c1<\/li>\n<li>\u3053\u308c\u3089\u306e\u56fd\u3067\u627f\u8a8d\u3055\u308c\u3066\u3044\u308b\u3001\u307e\u305f\u306f\u5e83\u304f\u4f7f\u7528\u3055\u308c\u3066\u3044\u308b\u304c\u3001\u56fd\u5185\u672a\u627f\u8a8d\u306e\u9069\u5fdc<\/li>\n<li>\u6b27\u7c73\u3067\u3082\u672a\u627f\u8a8d\u306e\u54c1\u76ee\u306e\u3046\u3061\u3001\u56fd\u5185\u3067\u7b2c\u2162\u76f8\u6cbb\u9a13\u304c\u5b9f\u65bd\u4e2d\u3082\u3057\u304f\u306f\u7d42\u4e86\u3057\u3066\u3044\u308b\u3082\u306e\u3001\u6a29\u5a01\u3042\u308b\u5b66\u8853\u96d1\u8a8c\u306b\u8ad6\u6587\u304c\u516c\u8868\u3055\u308c\u3066\u3044\u308b\u3082\u306e\u3001\u307e\u305f\u306f\u5148\u9032\u533b\u7642B\u3068\u3057\u3066\u306e\u5b9f\u7e3e\u304c\u3042\u308b\u3082\u306e<\/li>\n<\/ul>\n<p>2014\u5e746\u6708\u306b\u306f\u300c\u672a\u627f\u8a8d\u85ac\u8fc5\u901f\u5b9f\u7528\u5316\u30b9\u30ad\u30fc\u30e0\u300d\u304c\u5c0e\u5165\u3055\u308c\u307e\u3057\u305f\u3002\u7b2c\u2163\u56de\u8981\u671b\u306f2015\u5e747\u67081\u65e5\u304b\u3089\u968f\u6642\u53d7\u3051\u4ed8\u3051\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u540c\u7701\u30da\u30fc\u30b8\u306b\u63b2\u8f09\u3055\u308c\u3066\u3044\u308b\u76f4\u8fd1\u306e\u4f1a\u8b70\u306f\u7b2c68\u56de\uff082026\u5e745\u670825\u65e5\uff09\u3067\u3001\u305d\u308c\u4ee5\u524d\u306e4\u56de\u306f2026\u5e742\u67086\u65e5\u30012025\u5e7412\u670812\u65e5\u30012025\u5e749\u670829\u65e5\u30012025\u5e747\u67084\u65e5\u3067\u3059\u3002<\/p>\n<p>\u3053\u306e\u624b\u7d9a\u306e\u7d50\u679c\u81ea\u4f53\u3082\u516c\u958b\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u539a\u751f\u52b4\u50cd\u7701\u306f\u3001\u958b\u767a\u8981\u8acb\u3092\u884c\u3063\u305f\u307e\u305f\u306f\u958b\u767a\u4f01\u696d\u3092\u52df\u96c6\u3057\u305f\u533b\u85ac\u54c1\u306e\u30ea\u30b9\u30c8\u3092\u7dad\u6301\u3057\u3066\u304a\u308a\u3001\u6700\u7d42\u66f4\u65b0\u306f2025\u5e7412\u670815\u65e5\u3067\u3059\u3002<\/p>\n<h2>\u8abf\u9054\u5074\u3001\u3042\u308b\u3044\u306f\u8a2a\u65e5\u3092\u8003\u3048\u3066\u3044\u308b\u65b9\u306b\u3068\u3063\u3066\u306e\u610f\u5473<\/h2>\n<p>\u4e0a\u8a18\u306e\u7d4c\u8def\u306f\u5236\u5ea6\u7684\u306a\u3082\u306e\u3067\u3059\u3002\u5b66\u4f1a\u3001\u539a\u751f\u52b4\u50cd\u7701\u3001\u4f01\u696d\u3092\u901a\u308b\u9053\u3067\u3042\u308a\u3001\u500b\u4eba\u306e\u8cfc\u5165\u3084\u3001\u5378\u304c\u6c42\u3081\u306b\u5fdc\u3058\u3066\u8f38\u5165\u3059\u308b\u3068\u3044\u3046\u9053\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u65e5\u672c\u306e\u627f\u8a8d\u3092\u5f97\u3066\u3044\u306a\u3044\u54c1\u76ee\u306f\u3001\u6d77\u5916\u3067\u627f\u8a8d\u3055\u308c\u3066\u3044\u308b\u3068\u3044\u3046\u7406\u7531\u3060\u3051\u3067\u306f\u56fd\u5185\u6d41\u901a\u306b\u4e57\u308a\u307e\u305b\u3093\u3002\u533b\u7642\u4e0a\u306e\u5fc5\u8981\u6027\u304c\u3069\u308c\u307b\u3069\u9ad8\u304f\u3066\u3082\u3067\u3059\u3002<\/p>\n<p>\u6cd5\u4eba\u30d0\u30a4\u30e4\u30fc\u306b\u3068\u3063\u3066\u5b9f\u52d9\u7684\u306a\u542b\u610f\u306f\u3088\u308a\u72ed\u304f\u3001\u3088\u308a\u4f7f\u3048\u307e\u3059\u3002\u3042\u308b\u54c1\u76ee\u304c\u6d77\u5916\u306e\u627f\u8a8d\u30ea\u30b9\u30c8\u306b\u73fe\u308c\u305f\u3068\u304d\u3001\u65e5\u672c\u5074\u306e\u76f8\u624b\u306b\u78ba\u8a8d\u3059\u3079\u304d\u306f\u3001\u305d\u308c\u304c\u56fd\u5185\u3067\u4e09\u3064\u306e\u72b6\u614b\u306e\u3069\u308c\u306b\u3042\u308b\u304b\u2014\u2014\u627f\u8a8d\u6e08\u307f\u3001\u7533\u8acb\u4e2d\u3001\u307e\u3060\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306b\u5165\u3063\u3066\u3044\u306a\u3044\u2014\u2014\u3067\u3059\u3002\u3053\u306e\u4e09\u3064\u306f\u60f3\u5b9a\u3055\u308c\u308b\u6642\u9593\u8ef8\u304c\u307e\u3063\u305f\u304f\u7570\u306a\u308a\u307e\u3059\u3002<\/p>\n\n\n<figure class=\"wp-block-image size-full tsubaki-illustration--japan-pipeline-statuses\" data-tsubaki-illustration=\"japan-pipeline-statuses\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/japan-drug-pipeline-three-statuses-1.webp\" alt=\"Procurement specialists reviewing three generic status folders for approved, under-review and not-yet-filed medicines in Japan.\" class=\"wp-image-6657\" width=\"1536\" height=\"1024\" srcset=\"https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/japan-drug-pipeline-three-statuses-1.webp 1536w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/japan-drug-pipeline-three-statuses-1-300x200.webp 300w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/japan-drug-pipeline-three-statuses-1-1024x683.webp 1024w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/japan-drug-pipeline-three-statuses-1-768x512.webp 768w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/japan-drug-pipeline-three-statuses-1-600x400.webp 600w\" sizes=\"auto, (max-width: 1536px) 100vw, 1536px\" \/><\/figure>\n\n<h2>\u500b\u5225\u54c1\u76ee\u3092\u81ea\u5206\u3067\u78ba\u8a8d\u3059\u308b\u65b9\u6cd5<\/h2>\n<p>\u516c\u958b\u60c5\u5831\u306e\u56db\u3064\u3067\u304a\u304a\u3080\u306d\u8db3\u308a\u307e\u3059\u3002\u3044\u305a\u308c\u3082\u7121\u6599\u3067\u3059\u3002<\/p>\n<ul>\n<li><strong>FDA\u300cNovel Drug Approvals\u300d<\/strong>\u3067\u5e74\u6b21\u30ea\u30b9\u30c8\u3092\u3001Drugs@FDA\u3067\u500b\u5225\u306e\u627f\u8a8d\u8a18\u9332\u3092<\/li>\n<li><strong>PMDA<\/strong>\u3067\u56fd\u5185\u306e\u5be9\u67fb\u5831\u544a\u66f8\u3068\u627f\u8a8d\u60c5\u5831\u3092<\/li>\n<li><strong>\u539a\u751f\u52b4\u50cd\u7701\u306e\u958b\u767a\u8981\u8acb\u30ea\u30b9\u30c8<\/strong>\u3067\u3001\u672a\u627f\u8a8d\u85ac\u691c\u8a0e\u4f1a\u8b70\u3092\u901a\u3058\u3066\u65e2\u306b\u53d6\u308a\u4e0a\u3052\u3089\u308c\u3066\u3044\u308b\u304b\u3092<\/li>\n<li><strong>jRCT<\/strong>\uff08\u81e8\u5e8a\u7814\u7a76\u7b49\u63d0\u51fa\u30fb\u516c\u958b\u30b7\u30b9\u30c6\u30e0\uff09\u3067\u3001\u56fd\u5185\u8a66\u9a13\u304c\u52d5\u3044\u3066\u3044\u308b\u304b\u3092<\/li>\n<\/ul>\n<p>\u3044\u305a\u308c\u306e\u30da\u30fc\u30b8\u306b\u3082\u57fa\u6e96\u65e5\u304c\u8a18\u8f09\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u53c2\u7167\u3059\u308b\u524d\u306b\u305d\u306e\u4e00\u884c\u3092\u78ba\u8a8d\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u30ea\u30b9\u30c8\u306f\u52d5\u304d\u307e\u3059\u3002<\/p>\n\n\n<figure class=\"wp-block-image size-full tsubaki-illustration--public-source-verification\" data-tsubaki-illustration=\"public-source-verification\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/checking-public-drug-status-sources-1.webp\" alt=\"Researcher comparing four public regulatory and clinical research sources with date-check notes.\" class=\"wp-image-6658\" width=\"1672\" height=\"941\" srcset=\"https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/checking-public-drug-status-sources-1.webp 1672w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/checking-public-drug-status-sources-1-300x169.webp 300w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/checking-public-drug-status-sources-1-1024x576.webp 1024w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/checking-public-drug-status-sources-1-768x432.webp 768w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/checking-public-drug-status-sources-1-1536x864.webp 1536w, https:\/\/tsubaki-jp.com\/wp-content\/uploads\/2026\/08\/checking-public-drug-status-sources-1-600x338.webp 600w\" sizes=\"auto, (max-width: 1672px) 100vw, 1672px\" \/><\/figure>\n\n<p>\u65e5\u672c\u306e\u5236\u5ea6\u4e0a\u306e\u30ea\u30b9\u30c8\u304c\u3069\u3046\u69cb\u6210\u3055\u308c\u3001\u3069\u3046\u8aad\u3080\u306e\u304b\u306e\u5b9f\u4f8b\u306f\u3001<a href=\"https:\/\/tsubaki-jp.com\/ja\/carbon-ion-radiotherapy-advanced-medical-care-japan-ja\/\">\u5148\u9032\u533b\u7642A\u7b2c2\u53f7\u300c\u91cd\u7c92\u5b50\u7dda\u6cbb\u7642\u300d<\/a>\u306e\u8a18\u4e8b\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002\u56fd\u5185\u306e\u76f4\u8fd1\u52d5\u5411\u306f<a href=\"https:\/\/tsubaki-jp.com\/ja\/japan-pharma-briefs-20260727-ja\/\">\u65e5\u672c\u306e\u85ac\u4e8b\u30d6\u30ea\u30fc\u30d5<\/a>\u306b\u307e\u3068\u3081\u3066\u3044\u307e\u3059\u3002<\/p>\n<h2>FAQ<\/h2>\n<h3>2026\u5e747\u6708\u306bFDA\u306f\u65b0\u85ac\u3092\u4f55\u4ef6\u627f\u8a8d\u3057\u307e\u3057\u305f\u304b\u3002<\/h3>\n<p>FDA\u306e\u300cNovel Drug Approvals\u300d\u30da\u30fc\u30b8\u3067\u306f\u30012026\u5e747\u6708\u4ed8\u306e\u65b0\u85ac\u627f\u8a8d\u306f6\u4ef6\u3067\u3059\u3002\u3053\u306e\u4ef6\u6570\u306fCDER\u304c\u5be9\u67fb\u3057\u305f\u65b0\u6709\u52b9\u6210\u5206\u304a\u3088\u3073\u65b0\u898f\u6cbb\u7642\u7528\u751f\u7269\u88fd\u5264\u306e\u307f\u3092\u5bfe\u8c61\u3068\u3057\u3066\u304a\u308a\u3001\u65e2\u627f\u8a8d\u85ac\u306e\u9069\u5fdc\u62e1\u5927\u3068\u30d0\u30a4\u30aa\u30b7\u30df\u30e9\u30fc\u306f\u542b\u307f\u307e\u305b\u3093\u3002\u305d\u306e\u305f\u3081\u696d\u754c\u30e1\u30c7\u30a3\u30a2\u304c\u5831\u3058\u308b\u6708\u6b21\u306e\u7dcf\u6570\u306f\u901a\u5e38\u3053\u308c\u3088\u308a\u591a\u304f\u306a\u308a\u307e\u3059\u3002<\/p>\n<h3>FDA\u304c\u627f\u8a8d\u3059\u308c\u3070\u3001\u65e5\u672c\u3067\u3082\u8ca9\u58f2\u3067\u304d\u307e\u3059\u304b\u3002<\/h3>\n<p>\u3067\u304d\u307e\u305b\u3093\u3002\u65e5\u672c\u3067\u306e\u8ca9\u58f2\u306b\u306f\u85ac\u6a5f\u6cd5\u306b\u57fa\u3065\u304f\u65e5\u672c\u306e\u627f\u8a8d\u3092\u5225\u9014\u53d6\u5f97\u3059\u308b\u5fc5\u8981\u304c\u3042\u308a\u3001\u305d\u306e\u54c1\u76ee\u81ea\u8eab\u306e\u7533\u8acb\u8cc7\u6599\u306b\u3064\u3044\u3066\u65e5\u672c\u5074\u306e\u5be9\u67fb\u304c\u884c\u308f\u308c\u307e\u3059\u3002\u6d77\u5916\u306e\u627f\u8a8d\u306f\u65e5\u672c\u306b\u304a\u3044\u3066\u52b9\u529b\u3092\u6301\u305f\u305a\u3001\u4e21\u5236\u5ea6\u9593\u306e\u81ea\u52d5\u7684\u306a\u76f8\u4e92\u627f\u8a8d\u3082\u3042\u308a\u307e\u305b\u3093\u3002<\/p>\n<h3>\u6d77\u5916\u3067\u627f\u8a8d\u6e08\u307f\u306e\u533b\u85ac\u54c1\u3092\u65e5\u672c\u3067\u5be9\u67fb\u306b\u4e57\u305b\u308b\u516c\u5f0f\u306a\u65b9\u6cd5\u306f\u3042\u308a\u307e\u3059\u304b\u3002<\/h3>\n<p>\u3042\u308a\u307e\u3059\u3002\u539a\u751f\u52b4\u50cd\u7701\u304c\u300c\u533b\u7642\u4e0a\u306e\u5fc5\u8981\u6027\u306e\u9ad8\u3044\u672a\u627f\u8a8d\u85ac\u30fb\u9069\u5fdc\u5916\u85ac\u691c\u8a0e\u4f1a\u8b70\u300d\u3092\u958b\u50ac\u3057\u3066\u304a\u308a\u3001\u5b66\u4f1a\u304c\u8981\u671b\u3092\u63d0\u51fa\u3057\u307e\u3059\u3002\u5bfe\u8c61\u306f\u7c73\u82f1\u72ec\u4ecf\u52a0\u8c6a\u306e\u3044\u305a\u308c\u304b\u3067\u627f\u8a8d\u3055\u308c\u305f\u533b\u85ac\u54c1\u307e\u305f\u306f\u9069\u5fdc\u3067\u3001\u5fc5\u8981\u6027\u304c\u8a8d\u3081\u3089\u308c\u308c\u3070\u540c\u7701\u304c\u4f01\u696d\u306b\u958b\u767a\u8981\u8acb\u3092\u884c\u3046\u304b\u3001\u958b\u767a\u4f01\u696d\u3092\u516c\u52df\u3057\u307e\u3059\u3002<\/p>\n<h3>\u7279\u5b9a\u306e\u533b\u85ac\u54c1\u304c\u56fd\u5185\u3067\u627f\u8a8d\u3055\u308c\u3066\u3044\u308b\u304b\u306f\u3069\u3053\u3067\u78ba\u8a8d\u3067\u304d\u307e\u3059\u304b\u3002<\/h3>\n<p>PMDA\u304c\u56fd\u5185\u306e\u627f\u8a8d\u60c5\u5831\u3068\u5be9\u67fb\u5831\u544a\u66f8\u3092\u516c\u8868\u3057\u3066\u3044\u307e\u3059\u3002\u539a\u751f\u52b4\u50cd\u7701\u306f\u672a\u627f\u8a8d\u85ac\u691c\u8a0e\u4f1a\u8b70\u3092\u901a\u3058\u3066\u53d6\u308a\u4e0a\u3052\u3089\u308c\u305f\u54c1\u76ee\u306e\u30ea\u30b9\u30c8\u3092\u5225\u9014\u516c\u8868\u3057\u3066\u304a\u308a\u3001jRCT\u3067\u306f\u56fd\u5185\u306e\u81e8\u5e8a\u7814\u7a76\u306e\u767b\u9332\u72b6\u6cc1\u3092\u78ba\u8a8d\u3067\u304d\u307e\u3059\u3002\u3044\u305a\u308c\u306e\u30da\u30fc\u30b8\u306b\u3082\u57fa\u6e96\u65e5\u304c\u8a18\u8f09\u3055\u308c\u3066\u3044\u308b\u305f\u3081\u3001\u53c2\u7167\u524d\u306b\u78ba\u8a8d\u3057\u3066\u304f\u3060\u3055\u3044\u3002<\/p>\n<h2>\u53c2\u8003\u8cc7\u6599<\/h2>\n<ul>\n<li>U.S. Food and Drug Administration\u300cNovel Drug Approvals for 2026\u300d<a href=\"https:\/\/www.fda.gov\/drugs\/novel-drug-approvals-fda\/novel-drug-approvals-2026\" rel=\"noopener\" target=\"_blank\">\u30ea\u30f3\u30af<\/a>\uff08\u7c73\u56fd\u9023\u90a6\u653f\u5e9c\u306e\u8457\u4f5c\u7269\u3001\u30d1\u30d6\u30ea\u30c3\u30af\u30c9\u30e1\u30a4\u30f3\uff09<\/li>\n<li>\u539a\u751f\u52b4\u50cd\u7701\u300c\u533b\u7642\u4e0a\u306e\u5fc5\u8981\u6027\u306e\u9ad8\u3044\u672a\u627f\u8a8d\u85ac\u30fb\u9069\u5fdc\u5916\u85ac\u306e\u4eca\u5f8c\u306e\u8981\u671b\u52df\u96c6\u306b\u3064\u3044\u3066\u300d<a href=\"https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/iyakuhin\/misyounin\/index.html\" rel=\"noopener\" target=\"_blank\">\u30ea\u30f3\u30af<\/a>\uff08\u51fa\u5178\uff1a\u539a\u751f\u52b4\u50cd\u7701\u30db\u30fc\u30e0\u30da\u30fc\u30b8\uff09<\/li>\n<li>\u539a\u751f\u52b4\u50cd\u7701\u300c\u533b\u7642\u4e0a\u306e\u5fc5\u8981\u6027\u306e\u9ad8\u3044\u672a\u627f\u8a8d\u85ac\u30fb\u9069\u5fdc\u5916\u85ac\u691c\u8a0e\u4f1a\u8b70\u300d<a href=\"https:\/\/www.mhlw.go.jp\/stf\/shingi\/other-iyaku_128701.html\" rel=\"noopener\" target=\"_blank\">\u30ea\u30f3\u30af<\/a>\uff08\u51fa\u5178\uff1a\u539a\u751f\u52b4\u50cd\u7701\u30db\u30fc\u30e0\u30da\u30fc\u30b8\uff09<\/li>\n<li>\u539a\u751f\u52b4\u50cd\u7701\u300c\u958b\u767a\u4f01\u696d\u306e\u52df\u96c6\u53c8\u306f\u958b\u767a\u8981\u8acb\u3092\u884c\u3063\u305f\u533b\u85ac\u54c1\u306e\u30ea\u30b9\u30c8\u300d<a href=\"https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/iyakuhin\/kaihatsuyousei\/index.html\" rel=\"noopener\" target=\"_blank\">\u30ea\u30f3\u30af<\/a>\uff08\u51fa\u5178\uff1a\u539a\u751f\u52b4\u50cd\u7701\u30db\u30fc\u30e0\u30da\u30fc\u30b8\uff09<\/li>\n<li>AnswersNews\u300c2026\u5e747\u6708\u306b\u7c73FDA\u304c\u627f\u8a8d\u3057\u305f\u65b0\u85ac\u300d2026\u5e748\u67087\u65e5 <a href=\"https:\/\/answers.and-pro.jp\/pharmanews\/32994\/\" rel=\"noopener\" target=\"_blank\">\u30ea\u30f3\u30af<\/a> \u2014\u2014 \u672c\u8a18\u4e8b\u57f7\u7b46\u306e\u304d\u3063\u304b\u3051\u3068\u3057\u3066\u5f15\u7528\u3002\u5185\u5bb9\u306e\u8ee2\u8f09\u306f\u884c\u3063\u3066\u3044\u307e\u305b\u3093<\/li>\n<\/ul>\n<p><small>\u4e0a\u8a18\u51fa\u5178\u306b\u57fa\u3065\u304d\u4f5c\u6210\u3002\u539a\u751f\u52b4\u50cd\u7701\u30db\u30fc\u30e0\u30da\u30fc\u30b8\u306e\u516c\u8868\u8cc7\u6599\u3092\u52a0\u5de5\u3057\u3066\u4f5c\u6210\u3057\u3066\u3044\u307e\u3059\u3002<\/small><\/p>\n<p><small>\u60c5\u5831\u57fa\u6e96\u65e5\uff1a2026\u5e748\u670810\u65e5\u3002FDA\u30da\u30fc\u30b8\u306e\u5185\u5bb9\u57fa\u6e96\u65e5\u306f2026\u5e748\u67085\u65e5\u3001\u539a\u751f\u52b4\u50cd\u7701\u306e\u958b\u767a\u8981\u8acb\u30ea\u30b9\u30c8\u306e\u6700\u7d42\u66f4\u65b0\u306f2025\u5e7412\u670815\u65e5\u3067\u3059\u3002<\/small><\/p>\n<p><small>\u682a\u5f0f\u4f1a\u793e Tsubaki Trading \u306f\u6771\u4eac\u90fd\u77e5\u4e8b\u306e\u533b\u85ac\u54c1\u5378\u58f2\u8ca9\u58f2\u696d\u8a31\u53ef\uff08\u7b2c5313250689\u53f7\uff09\u3092\u6709\u3059\u308b\u65e5\u672c\u306e\u767b\u8a18\u4f01\u696d\u3067\u3042\u308a\u3001\u3053\u308c\u3089\u306e\u6cd5\u4ee4\u30fb\u544a\u793a\u8cc7\u6599\u3092\u65e5\u5e38\u7684\u306b\u53d6\u308a\u6271\u3063\u3066\u3044\u307e\u3059\u3002\u672c\u8a18\u4e8b\u306f\u60c5\u5831\u63d0\u4f9b\u306e\u307f\u3092\u76ee\u7684\u3068\u3057\u3001\u8a3a\u65ad\u30fb\u6cbb\u7642\u30fb\u670d\u85ac\u306b\u95a2\u3059\u308b\u52a9\u8a00\u3067\u306f\u306a\u304f\u3001\u533b\u7642\u7528\u533b\u85ac\u54c1\u306e\u5e83\u544a\u3067\u3082\u3042\u308a\u307e\u305b\u3093\u3002\u7de8\u96c6\u65b9\u91dd\u306f<a href=\"https:\/\/tsubaki-jp.com\/ja\/editorial-policy-ja\/\">\u7de8\u96c6\u65b9\u91dd\u30fb\u533b\u85ac\u60c5\u5831\u30dd\u30ea\u30b7\u30fc<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/small><\/p>","protected":false},"excerpt":{"rendered":"<p>2026\u5e747\u6708\u3001FDA\u306f\u65b0\u85ac6\u4ef6\u3092\u627f\u8a8d\u3057\u307e\u3057\u305f\u3002\u7c73\u56fd\u306e\u627f\u8a8d\u306f\u65e5\u672c\u3067\u306f\u52b9\u529b\u3092\u6301\u3061\u307e\u305b\u3093\u3002\u6d77\u5916\u627f\u8a8d\u85ac\u3092\u56fd\u5185\u5be9\u67fb\u306b\u4e57\u305b\u308b\u516c\u5f0f\u7d4c\u8def\u3092\u3001\u4e00\u6b21\u8cc7\u6599\u306b\u6cbf\u3063\u3066\u6574\u7406\u3057\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":6653,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[739],"tags":[],"class_list":["post-6623","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-news-ja"],"_links":{"self":[{"href":"https:\/\/tsubaki-jp.com\/ja\/wp-json\/wp\/v2\/posts\/6623","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tsubaki-jp.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tsubaki-jp.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tsubaki-jp.com\/ja\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tsubaki-jp.com\/ja\/wp-json\/wp\/v2\/comments?post=6623"}],"version-history":[{"count":2,"href":"https:\/\/tsubaki-jp.com\/ja\/wp-json\/wp\/v2\/posts\/6623\/revisions"}],"predecessor-version":[{"id":6660,"href":"https:\/\/tsubaki-jp.com\/ja\/wp-json\/wp\/v2\/posts\/6623\/revisions\/6660"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tsubaki-jp.com\/ja\/wp-json\/wp\/v2\/media\/6653"}],"wp:attachment":[{"href":"https:\/\/tsubaki-jp.com\/ja\/wp-json\/wp\/v2\/media?parent=6623"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tsubaki-jp.com\/ja\/wp-json\/wp\/v2\/categories?post=6623"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tsubaki-jp.com\/ja\/wp-json\/wp\/v2\/tags?post=6623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}